MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 262 filers reported holding MYRIAD GENETICS INC in Q2 2013. The put-call ratio across all filers is 3.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $646,000 | -70.7% | 25,000 | -78.3% | 0.11% | -67.4% |
| Q1 2017 | $2,208,000 | +15.2% | 115,000 | 0.0% | 0.34% | +5.3% |
| Q4 2016 | $1,917,000 | -19.0% | 115,000 | 0.0% | 0.32% | -29.3% |
| Q3 2016 | $2,367,000 | +3.7% | 115,000 | +71.6% | 0.46% | +33.6% |
| Q4 2014 | $2,282,000 | -37.7% | 67,000 | -29.5% | 0.34% | -41.4% |
| Q3 2014 | $3,664,000 | -0.9% | 95,000 | 0.0% | 0.58% | +10.8% |
| Q2 2014 | $3,697,000 | +13.8% | 95,000 | 0.0% | 0.53% | +8.2% |
| Q1 2014 | $3,248,000 | +63.0% | 95,000 | 0.0% | 0.49% | +72.1% |
| Q4 2013 | $1,993,000 | +72.6% | 95,000 | +120.9% | 0.28% | +42.2% |
| Q2 2013 | $1,155,000 | – | 43,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |